Navigation Links
Covance Reports Second Quarter Net Revenue of $592 Million, Pro Forma EPS of $0.78 and Record Adjusted Net Orders of $776 Million
Date:7/30/2013

PRINCETON, N.J., July 30, 2013 /PRNewswire/ -- Covance Inc. (NYSE: CVD) today reported results for its second quarter ended June 30, 2013.  Net revenue was $592.3 million, representing 9.1% growth from the second quarter of 2012's GAAP result of $542.8 million, and 10.0% growth from the second quarter of 2012's pro forma result of $538.5 million.  On a GAAP basis, the company reported earnings of $0.72 per diluted share in the second quarter.  Excluding charges associated with restructuring and other cost reduction actions totaling $6.0 million and a gain on the sale of an equity investment of $0.7 million, the company reported earnings per diluted share of $0.78, up 19.9% over the pro forma earnings of $0.65 for the second quarter of 2012. 

"Accelerated revenue growth in central laboratories was the primary driver of better-than-expected consolidated results in the second quarter, including pro forma revenue growth of 10%, operating margin of 9.7%, and EPS growth of 20% to $0.78," said Joe Herring, Chairman and Chief Executive Officer. "Strong commercial performance, led by clinical development, delivered record adjusted net orders of $776 million in the quarter. These orders result in an adjusted net book-to-bill of 1.31 to 1.  

"Late-Stage Development second quarter revenue grew 17% year-on-year to $378 million and pro forma operating margins were 21.4%, up 30 basis points from a year ago despite increased spending on strategic IT projects.  Better-than-expected kit volumes in central laboratories drove both year-over-year revenue growth of 22% and operating margin expansion.  Clinical development grew revenue 13% year-on-year and delivered record adjusted net orders.

"In Early Development, revenue of $215 million was flat from last year's pro forma result as strong revenue growth in nutritional chemistry and clinical p
'/>"/>

SOURCE Covance Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Covance Central Laboratory Services Again Ranks #1 in Global Investigator Satisfaction Survey
2. Covance To Present At The Goldman Sachs 34th Annual Global Healthcare Conference
3. Covance Reports First Quarter Net Revenue Growth Of 9.3% To $580 Million, Pro Forma EPS Of $0.75 And Adjusted Net Orders Of $716 Million
4. Covance Expands Singapore Central Laboratory by 50 Percent to Meet Clients Increased Asia Pacific Focus
5. Covance Inc. Invites You to Join the Webcast of Its First Quarter 2013 Financial Results Conference Call
6. Covance To Present At The Citi 2013 Global Healthcare Conference
7. Covance To Present At The Leerink Swann Global Healthcare Conference
8. Covance Reports Fourth Quarter Pro Forma Net Revenue Of $561 Million, Pro Forma EPS Of $0.73 And Adjusted Net Orders Of $769 Million
9. Covance To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
10. Covance Reports Third Quarter Pro Forma Net Revenue Of $542 Million, Pro Forma EPS Of $0.72 And Adjusted Net Orders Of $701 Million
11. Covance to Present at the Morgan Stanley Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... Oct. 30, 2014 CVS Health (NYSE: ... affiliations with three leading regional health systems to enhance access ... health systems include Baptist Health System in Alabama ... Commonwealth Health in Pennsylvania , Northwest Medical ... , and Tennova Healthcare in Tennessee ; ...
(Date:10/30/2014)... , Oct. 30, 2014   BioLife Solutions , ... manufacturer and marketer of proprietary clinical grade hypothermic ... precision thermal shipping products for cells and ... 2014 financial results will be released on Thursday, November ... conference call and live webcast at 1:30 p.m. PST ...
(Date:10/30/2014)... October 30, 2014 , ... LGG contribuye a adquirir tolerancia a la proteína ... la proteína de la leche de la vaca (APLV) ... infancia. Hasta ahora, la APLV se trataba eliminando ... ha demostrado que es posible adquirir tolerancia oral ...
Breaking Medicine Technology:CVS Health Announces New Clinical Affiliations with Leading Regional Health Systems 2CVS Health Announces New Clinical Affiliations with Leading Regional Health Systems 3CVS Health Announces New Clinical Affiliations with Leading Regional Health Systems 4BioLife Solutions to Report Financial Results for Third Quarter 2014 and Provide Business Update on November 6, 2014 2Según expertos reunidos en el Simposio Allergy Day 2Según expertos reunidos en el Simposio Allergy Day 3
... Conn., Sept. 16 Amarin Corporation plc (Nasdaq: ... is scheduled to present on Amarin,s behalf at the Global ... 12:30 pm. This conference will be held at the Grand ... appointed as President and Chief Executive Officer, will also be ...
... Wis., Sept. 16 Top researchers at the Gastrointestinal ... Dallas are exploring the clinical applications of BCM-95®, a ... bioavailability. Previous studies have shown that ... forms of curcumin, and had a retention time in ...
Cached Medicine Technology:Amarin to Present at UBS Life Sciences Conference 2BCM-95 Demonstrates Superior Anti-Inflammatory Effects 2
(Date:10/30/2014)... October 30, 2014—(BRONX, NY)—Investigators at Albert Einstein ... and Montefiore Medical Center will present their ... America,s (GSA) 67th Annual Scientific Meeting. Topics include ... survival, risk factors for cognitive impairment and the ... place November 5-9, 2014 in Washington, D.C., "Einstein-Montefiore ...
(Date:10/30/2014)... developed by NIH grantees predicts that women must take ... via vaginal sex, whereas just two doses per week ... This finding helps explain why two large clinical trials ... to show efficacy. Participants in the VOICE ... (another antiretroviral) for HIV prevention were counseled to take ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 High ... exclusive concepts in the medical-grade skin care domain: ... development of uniquely potent topical dermatological products, today ... ( http://www.RefinitySkinScience.com ) with patented COSMEDERM®-7 anti-irritant technology. ... acid concentrations (50% and 70%) and a low ...
(Date:10/30/2014)... HealthDay Reporter , WEDNESDAY, Oct. 29, ... prostate cancer who also have certain heart problems may increase ... study suggests. , , The therapy in question is called androgen ... levels of male hormones to prevent the growth of cancer ... this hormone therapy was linked to triple the risk of ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 Horse ... therapeutic horseback riding to special needs individuals in the ... on Saturday, November 15 from 10-2:00 p.m. at Bailey's ... is open to the public and is designed to ... , Admission to the HSS Round-Up is free. Ticket ...
Breaking Medicine News(10 mins):Health News:Einstein-Montefiore investigators present aging research at Gerontological Society of America's Annual Scientific Meeting 2Health News:Einstein-Montefiore investigators present aging research at Gerontological Society of America's Annual Scientific Meeting 3Health News:Einstein-Montefiore investigators present aging research at Gerontological Society of America's Annual Scientific Meeting 4Health News:Model by NIH grantees explains why HIV prevention dosing differs by sex 2Health News:Cosmederm Redefines Peel Science Standard with Launch of Refinity® Skin Health System 2Health News:Cosmederm Redefines Peel Science Standard with Launch of Refinity® Skin Health System 3Health News:Cosmederm Redefines Peel Science Standard with Launch of Refinity® Skin Health System 4Health News:Hormone Therapy May Up Heart-Related Deaths in Some Prostate Cancer Patients 2Health News:Hormone Therapy May Up Heart-Related Deaths in Some Prostate Cancer Patients 3Health News:Horse Sense & Sensitivity, Jacksonville Non-profit, To Hold 2nd Annual Round-Up 2
... Millions of Americans whose vision is slowly ebbing due to ... the lowly neural progenitor cell may be useful for restoring ... rats, neural progenitor cells derived from human fetal stem cells ... degenerative eye disease similar to the kinds of diseases that ...
... pill to control high blood pressure and new drugs ... Clinic researchers have designed two promising new cardiovascular treatment ... pill form to lower high blood pressure and a ... kidney function. ,In the process, they ...
... the popular anti-clotting drug clopidogrel (Plavix) when taken along with ... adverse bleeding event.// ,The study, to be ... Session on March 27 at 9 am (abstract 1027-18), found ... worsen bleeding after off-pump heart bypass surgery. ...
... multi-center study concludes that women with a recent diagnosis of ... opposite breast.// ,This study was conducted by ... ,The international research team found that MRI, or ... 30 of 969 women (3.1 percent) who had recently been ...
... against a virus that causes cervical cancer.// ,The ... has recommended the universal vaccination of girls aged 12 to ... Health has announced that vaccination of 12 years old girls ... are prepared. ,Government advisors are considering whether ...
... MPs has come together to launch a fight against tuberculosis ... massive awareness drive and also seeking a special fund to ... least two people die of the infectious disease every three ... to form a group next month and to persuade other ...
Cached Medicine News:Health News:Stem Cell Therapy Shows Promise for Rescuing Deteriorating Vision 2Health News:Stem Cell Therapy Shows Promise for Rescuing Deteriorating Vision 3Health News:Hormone-based Heart Pill to Control High Blood Pressure 2Health News:Hormone-based Heart Pill to Control High Blood Pressure 3Health News:Plavix Safe During and After Heart Bypass 2Health News:MRI Screening of Other Breast Crucial for Patients Diagnosed With Cancer in One Breast 2Health News:Indian Parliamentarians Join to Fight Against TB 2
... day surgery and post anesthesia care in one ... is a high performance monitor designed for the ... and induction rooms. It offers the flexibility of ... advanced airway gas monitoring. When paired with the ...
... The complete picture of patient respiration and ... the most versatile respiration and ventilation monitors available. ... models. Each model allows you to measure the ... O 2 , and N 2 O easily ...
For accurately monitoring heart and breath sounds....
For accurately monitoring core temperature and heart and breath sounds....
Medicine Products: